A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

US sweet protein startup Oobli has raised $18M and partnered with global ingredients giant Ingredion to develop ...

More and more Americans are turning to GLP-1 injections to lose weight. FOX 7 Austin's Rebecca Thomas spoke to an Austin physician to discuss.

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

The researchers found that both SGLT2 inhibitors and GLP-1 agonists were associated with a lower risk of major cardiovascular events, but the drug effects varied with the patients’ age.

Unlike conventional approaches, these medications may do more than manage symptoms - they may work at a biological ... 2 SGLT2 inhibitors and GLP-1 receptor agonists: which is the best anti ...